According to the WHO classification, 107 (42.1%) patients had PTCL-NOS, 54 (21.3%) had extranodal NK/T-cell lymphoma, 48 (18.9%) had AITL, and 28 (11.0%) had ALK-negative ALCL in the auto-SCT group. The gene discussed is ALK; the disease is extranodal nasal NK/T cell lymphoma.